Trial reports transplant success in dyskeratosis congenita, a rare bone marrow failure syndrome, following conditioning with immunosuppressive drugs alone
Researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients w…
Researchers report promising outcomes from clinical trial in patients with dyskeratosis congenita
Monday, December 8, 2014
Researchers report promising outcomes from clinical trial in patients with dyskeratosis congenita
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment